Works matching IS 24501654 AND DT 2020 AND VI 16 AND IP 6
Results: 5
The search for causes of resistance to pembrolizumab in lung adenocarcinoma with PD-L1 expression -- focus on intestinal microbiome.
- Published in:
- Oncology in Clinical Practice (2450-1654), 2020, v. 16, n. 6, p. 364, doi. 10.5603/OCP.2020.0031
- By:
- Publication type:
- Article
Rectal cancer (C20).
- Published in:
- Oncology in Clinical Practice (2450-1654), 2020, v. 16, n. 6, p. 338, doi. 10.5603/OCP.2020.0042
- By:
- Publication type:
- Article
New dosing schedule of pembrolizumab -- theoretical basis and scientific evidence.
- Published in:
- Oncology in Clinical Practice (2450-1654), 2020, v. 16, n. 6, p. 358, doi. 10.5603/OCP.2020.0033
- By:
- Publication type:
- Article
Carcinoma of the anal canal and anal margin.
- Published in:
- Oncology in Clinical Practice (2450-1654), 2020, v. 16, n. 6, p. 331, doi. 10.5603/OCP.2020.0036
- By:
- Publication type:
- Article
Polish Society of Clinical Oncology and Polish Urological Association Guidelines for the diagnosis and treatment of renal cell cancer.
- Published in:
- Oncology in Clinical Practice (2450-1654), 2020, v. 16, n. 6, p. 301, doi. 10.5603/OCP.2020.0029
- By:
- Publication type:
- Article